(Reuters) - Mylan NV said on Friday it would start selling a generic version of its life-saving EpiPen allergy treatment at a more than 50 percent discount, a day after 20 U.S. states filed a lawsuit against generic drugmakers including Mylan over prices.
from Reuters: U.S. http://ift.tt/2gIQCNP
No comments:
Post a Comment